Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes

被引:31
作者
Bäck, M [1 ]
Norel, X
Walch, L
Gascard, JP
Mazmanian, G
Dahlén, SE
Brink, C
机构
[1] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
[2] Ctr Chirurg Marie Lannelongue, CNRS, ESA 8078, F-92350 Le Plessis Robinson, France
基金
英国医学研究理事会;
关键词
pulmonary artery; porcine; leukotriene; contraction; CysLT receptor; ICI 204,219; BAY u9773;
D O I
10.1016/S0014-2999(00)00452-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The contractile response to cysteinyl-leukotrienes was studied in isolated porcine pulmonary arterial rings. In endothelium-denuded preparations, the concentration-response curves for leukotriene C-4 and leukotriene D-4 were identical, whereas leukotriene E-4 did not contract these tissues. The response to leukotriene C-4 was not blocked by either CysLT(1)/CysLT(2) receptor antagonism or by pre-treatment with leukotriene E-4. In preparations with an intact endothelium, leukotriene C-4 was somewhat more potent than leukotriene D-4 and the concentration-response curves were only slightly depressed in the presence of either ICI 204,219 (4-(5-cyclopentyloxycarbonylamino-1-methylindol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide, 1 mu M) or BAY u9773 (6(R)-(4'-carboxyphenylthio)-5(S)-hydroxy-7( E),9(E), 11(Z)14(Z)-eicosatetrenoic acid, 3 mu M). Indomethacin (1.7 mu M) significantly reduced the response to leukotriene C-4 whereas the response to leukotriene D-4 was unchanged. These findings suggest that a CysLT receptor subtype resistant to current antagonists mediated the major part of the contractions to leukotriene C-4 and leukotriene D-4 in intact preparations, and was the sole receptor associated with contractions of endothelium-denuded preparations. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 33 条
  • [1] The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C-4 in the guinea-pig ileum
    Back, M
    Jonsson, EW
    Dahlen, SE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 317 (01) : 107 - 113
  • [2] Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes
    Bäck, M
    Norel, X
    Walch, L
    Gascard, JP
    de Montpreville, V
    Dahlén, SE
    Brink, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (03) : 389 - 395
  • [3] BERKOWITZ BA, 1984, J PHARMACOL EXP THER, V229, P105
  • [4] EFFECTS OF VARIOUS PHARMACOLOGICAL AGENTS ON ISOLATED HUMAN BRONCHIAL AND PULMONARY ARTERIAL AND VENOUS MUSCLE PREPARATIONS CONTRACTED BY LEUKOTRIENE-D4
    BOURDILLAT, B
    HAYELEGRAND, I
    LABAT, C
    RAFFESTIN, B
    NOREL, X
    BENVENISTE, J
    BRINK, C
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1987, 1 (06) : 433 - 444
  • [5] BRINK C, 1981, J PHARMACOL EXP THER, V219, P1
  • [6] BUCKNER CK, 1986, J PHARMACOL EXP THER, V237, P558
  • [7] BUCKNER CK, 1990, J PHARMACOL EXP THER, V252, P77
  • [8] Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma
    Capra, V
    Nicosia, S
    Ragnini, D
    Mezzetti, M
    Keppler, D
    Rovati, GE
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (04) : 750 - 758
  • [9] COLEMAN RA, 1995, ADV PROSTAG THROMB L, V23, P283
  • [10] COMPARATIVE AIRWAY AND VASCULAR ACTIVITIES OF LEUKOTRIENE-C-1 AND LEUKOTRIENE-D INVIVO AND INVITRO
    DRAZEN, JM
    AUSTEN, KF
    LEWIS, RA
    CLARK, DA
    GOTO, G
    MARFAT, A
    COREY, EJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07): : 4354 - 4358